secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001437749-24-016081
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics enters $3.85M ATM equity offering agreement with H.C. Wainwright
--------------------------------------------------------------------------------

- Company entered ATM offering agreement with H.C. Wainwright for up to $3,850,000 in common stock sales.
- Manager receives 3.0% commission on gross proceeds; Company provides customary indemnification and contribution rights.
- Offering is 'at the market' under Rule 415; Company may sell shares at its discretion over time.
- Agreement terminates upon sale of all shares or earlier termination by either party on specified prior notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/0001437749-24-016081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924016081/atxi20240510_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-016081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer